Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Chiara Pelliccia"'
Publikováno v:
Geriatric Care, Vol 6, Iss 3 (2020)
Glyphozines also called SGLT2 inhibitors, are a new class of agents that inhibit reabsorption of glucose in the kidney, in proximal tubules, and therefore lower blood sugar. They act by inhibiting sodiumglucose transport protein 2 (SGLT2). Glyphozine
Externí odkaz:
https://doaj.org/article/098de08960944730acc042bce90a0723
Publikováno v:
Italian Journal of Medicine (2020)
For some patients with SARS-CoV-2, the worst clinical damage is not caused by the virus itself, but by an overactive inflammatory state. In fact, in some people the immune system goes into overdrive and launches a large-scale assault on the tissue kn
Externí odkaz:
https://doaj.org/article/2d9e05bda5b8464f9294d65bd4caadf1
Autor:
Giacomo Ciacca, Alfredo Di Giovanni, Luigi Califano, Vito Enrico Pettorossi, Giampietro Ricci, Chiara Pelliccia, Mario Faralli
Publikováno v:
Acta Otorhinolaryngologica Italica. 43:140-148
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76242eee09409f4d6f27d6bdf76a234f
https://doi.org/10.14639/0392-100x-n2152
https://doi.org/10.14639/0392-100x-n2152
Publikováno v:
European Journal of Clinical Pharmacology. 76:1615-1618
SARS-CoV-2 infection has been divided by scientific opinion into three phases: the first as asymptomatic or slightly symptomatic and the second and the third with greater severity, characterized by a hyperinflammatory and fibrotic state, responsible
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abf76fc4632db9d7886c895fd29f3022
https://doi.org/10.1007/s00228-020-02947-4
https://doi.org/10.1007/s00228-020-02947-4
Autor:
Alessio Gili, Massimo Lancia, Isabella Mercurio, Mauro Bacci, Alessia Nicoletti, Chiara Pelliccia, Cristiana Gambelunghe
Publikováno v:
Healthcare; Volume 10; Issue 4; Pages: 710
Polydrug use is a serious health and social problem worldwide. Treatment remains a challenge because it requires planning based on estimates of the nature and extent of drug consumption and the characteristics of the population in need. To this end,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0c12146793075f9ef7e604879647b14
https://pubmed.ncbi.nlm.nih.gov/35455887
https://pubmed.ncbi.nlm.nih.gov/35455887
Autor:
Anne-Madeleine Goulet, Michela Berti, Orsetta Baroncelli, Diana Blichmann, Teresa Chirico, Émilie Corswarem, Valeria De Lucca, José María Domínguez, Gloria Giordano, Chiara Pelliccia, Antonella Fabriani Rojas, Cristina Fernandes, Irene Fosi, Natalia Gozzano, Manuela Grillo, Letizia Leli, Sarah Malfatti, Benoît Maréchaux, Margaret Murata, Giulia Veneziano, Barbara Nestola, Alexandra Nigito, Elodie Oriol, Valentina Panzanaro, Maurizio Pegrari, Aldo Roma, Marco Cavietti, Sara Elisa Stangalino, Huub van Der Linden
Publikováno v:
Brepols, In press, Vendrix, Philippe
HAL
HAL
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ebfd3aae21a5ddae429f6e0002e0dff4
https://hal.science/hal-03904629
https://hal.science/hal-03904629
Publikováno v:
Drug Discovery Today
Highlights • The angiotensin-converting enzyme 2 (ACE-2) facilitates access of SARS-CoV-2 in cells. • Therapeutic modulation of ACE-2 could be of clinical benefit. • Drugs acting on RAS should not be discontinued. • An increase of ACE-2 can p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8e3cb7a5bdbd354942b9fbe5a46f922
Autor:
CHIARA PELLICCIA
Publikováno v:
Spectacles et performances artistiques à Rome (1644-1740) : Une analyse historique à partir des archives familiales de l'aristocratie
CHIARA PELLICCIA
CHIARA PELLICCIA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::aa0bf92c2f957ae5539ccc58a3eae6ec
Publikováno v:
SN Comprehensive Clinical Medicine
Sn Comprehensive Clinical Medicine
Sn Comprehensive Clinical Medicine
In December 2019, the first data emerged from Wuhan, China, of a serious acute respiratory disease caused by a new coronavirus, SARS-CoV-2 (COVID-19). In a short time, the health emergency became a global pandemic. To date, there are about 18.8 milli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd1c952f9e09aec5d25064106ce29da7
Publikováno v:
Universal Journal of Pharmaceutical Research.
Research in present time has been focusing on finding a specific SARS-CoV-2 vaccine or antiviral, which will probably be the therapeutic goal in the fight against the virus. In the meantime, scientific evidence shows that it is possible to have effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df6933b08752a5e8d7db53e3786ec877
https://doi.org/10.22270/ujpr.v5i3.417
https://doi.org/10.22270/ujpr.v5i3.417